Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Cortesi

Showing results (51-60 of 181) with videos related to

Pageof 19
Sort By:
BMC Cancer|August 19, 2006
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experienceLaura Cortesi, Daniela Turchetti, Isabella Marchi, et al.
Oncotarget|November 24, 2016
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutationAngela Toss, Giovanni Grandi, Angelo Cagnacci, et al.
BMC Cancer|January 25, 2006
Prognosis of screen-detected breast cancers: results of a population based studyLaura Cortesi, Vincenzo E Chiuri, Silvia Ruscelli, et al.
International Journal of Cancer|August 24, 2012
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent yearsLaura Cortesi, Luigi Marcheselli, Valentina Guarneri, et al.
Journal of Diabetes Research|May 12, 2015
Effectiveness of a nurse-managed protocol to prevent hypoglycemia in hospitalized patients with diabetesGiuseppe Marelli, Fausto Avanzini, Giuseppe Iacuitti, et al.
Oncology|August 30, 2017
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort StudyLaura Cortesi, Elisabetta De Matteis, Angela Toss, et al.
Future Oncology (London, England)|November 25, 2024
Homologous recombination deficiency in pancreatic neuroendocrine tumorsCamilla Bardasi, Elena Tenedini, Lia Bonamici, et al.
Cancer Biology & Medicine|March 12, 2021
<i>BRCA</i> mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigreesLaura Cortesi, Federica Domati, Annalisa Guida, et al.
Clinical Breast Cancer|September 29, 2023
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-AnalysisRaffaella D'Onofrio, Isabella Sperduti, Federico Piacentini, et al.
Clinical Breast Cancer|August 21, 2019
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysisAngela Toss, Marta Venturelli, Isabella Sperduti, et al.
Pageof 19

Showing results (51-60 of 181) with videos related to

Sort By:
Pageof 19
BMC Cancer|August 19, 2006
Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experienceLaura Cortesi, Daniela Turchetti, Isabella Marchi, et al.
Oncotarget|November 24, 2016
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutationAngela Toss, Giovanni Grandi, Angelo Cagnacci, et al.
BMC Cancer|January 25, 2006
Prognosis of screen-detected breast cancers: results of a population based studyLaura Cortesi, Vincenzo E Chiuri, Silvia Ruscelli, et al.
International Journal of Cancer|August 24, 2012
Tumor size, node status, grading, HER2 and estrogen receptor status still retain a strong value in patients with operable breast cancer diagnosed in recent yearsLaura Cortesi, Luigi Marcheselli, Valentina Guarneri, et al.
Journal of Diabetes Research|May 12, 2015
Effectiveness of a nurse-managed protocol to prevent hypoglycemia in hospitalized patients with diabetesGiuseppe Marelli, Fausto Avanzini, Giuseppe Iacuitti, et al.
Oncology|August 30, 2017
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort StudyLaura Cortesi, Elisabetta De Matteis, Angela Toss, et al.
Future Oncology (London, England)|November 25, 2024
Homologous recombination deficiency in pancreatic neuroendocrine tumorsCamilla Bardasi, Elena Tenedini, Lia Bonamici, et al.
Cancer Biology & Medicine|March 12, 2021
<i>BRCA</i> mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigreesLaura Cortesi, Federica Domati, Annalisa Guida, et al.
Clinical Breast Cancer|September 29, 2023
Thromboembolism and Adjuvant Endocrine Therapy (AET) in Hormone Receptor-Positive Early Breast Cancer (EBC): Did Treatment Evolution Change Incidence of the Adverse Event? A Meta-AnalysisRaffaella D'Onofrio, Isabella Sperduti, Federico Piacentini, et al.
Clinical Breast Cancer|August 21, 2019
First-Line Treatment for Endocrine-Sensitive Bone-Only Metastatic Breast Cancer: Systematic Review and Meta-analysisAngela Toss, Marta Venturelli, Isabella Sperduti, et al.
Pageof 19